-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
QLY Biotech Group Corp. quarterly and annual Revenues in USD history and change rate from 28 Feb 2019 to 28 Feb 2023.
- QLY Biotech Group Corp. Revenues for the quarter ending 28 Feb 2023 was $0.
- QLY Biotech Group Corp. Revenues for the twelve months ending 28 Feb 2023 was $0, a 100% decline year-over-year.
- QLY Biotech Group Corp. annual Revenues for 2022 was $0, a 100% decline from 2021.
- QLY Biotech Group Corp. annual Revenues for 2021 was $4,000, unchanged from 2020.
- QLY Biotech Group Corp. annual Revenues for 2020 was $4,000.